TY - JOUR
T1 - Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism
AU - Edelheit, Oded
AU - Hanukoglu, Israel
AU - Gizewska, Maria
AU - Kandemir, Nurgun
AU - Tenenbaum-Rakover, Yardena
AU - Yurdakök, Murat
AU - Zajaczek, Stanislaw
AU - Hanukoglu, Aaron
PY - 2005/5
Y1 - 2005/5
N2 - Objectives: Multisystem pseudohypoaldosteronism (PHA) is a rare autosomal recessive aldosterone unresponsiveness syndrome that results from mutations in the genes encoding epithelial sodium channel (ENaC) subunits α, β and γ. In this study we examined three PHA patients to identify mutations responsible for PHA with different clinical presentations. Patients: All three patients presented uniformly with symptoms of severe salt-loss during the first week of life and were hospitalized for up to a year. Beyond infancy, one of the patients showed mild renal salt loss and had no lower respiratory tract infections until 8 years of age, while the other patients continue with a severe course. Results: We sequenced the complete coding regions and intron-exon junctions of the genes encoding α, β and γ subunits of ENaC for all patients. The results revealed that the mild case represents a novel compound heterozygote including a missense (Gly327Cys) mutation in the αENaC gene. Sequences of relatives over three generations confirmed that the missense mutation co-segregates with PHA. This mutation was not found in 60 control subjects. The other patients with severe PHA had two homozygous mutations, a novel deletion mutation in exon 8 of the αENaC gene and a splice site mutation in intron 12 of the βENaC gene. Most of the PHA-causing mutations appear in the αENaC gene located on chromosome 12 rather than in the β and γENaC genes located tandemly on chromosome 16. However, the frequency of sequence variants in patients and control subjects showed no difference between genes. Conclusions: Severe PHA cases are associated with mutations leading to absence of normal-length α, β or γENaC, while a mild case has been found to be associated with a missense mutation in αENaC. The predominance of PHA-causing mutations in the αENaC gene may be related to the function of this subunit.
AB - Objectives: Multisystem pseudohypoaldosteronism (PHA) is a rare autosomal recessive aldosterone unresponsiveness syndrome that results from mutations in the genes encoding epithelial sodium channel (ENaC) subunits α, β and γ. In this study we examined three PHA patients to identify mutations responsible for PHA with different clinical presentations. Patients: All three patients presented uniformly with symptoms of severe salt-loss during the first week of life and were hospitalized for up to a year. Beyond infancy, one of the patients showed mild renal salt loss and had no lower respiratory tract infections until 8 years of age, while the other patients continue with a severe course. Results: We sequenced the complete coding regions and intron-exon junctions of the genes encoding α, β and γ subunits of ENaC for all patients. The results revealed that the mild case represents a novel compound heterozygote including a missense (Gly327Cys) mutation in the αENaC gene. Sequences of relatives over three generations confirmed that the missense mutation co-segregates with PHA. This mutation was not found in 60 control subjects. The other patients with severe PHA had two homozygous mutations, a novel deletion mutation in exon 8 of the αENaC gene and a splice site mutation in intron 12 of the βENaC gene. Most of the PHA-causing mutations appear in the αENaC gene located on chromosome 12 rather than in the β and γENaC genes located tandemly on chromosome 16. However, the frequency of sequence variants in patients and control subjects showed no difference between genes. Conclusions: Severe PHA cases are associated with mutations leading to absence of normal-length α, β or γENaC, while a mild case has been found to be associated with a missense mutation in αENaC. The predominance of PHA-causing mutations in the αENaC gene may be related to the function of this subunit.
UR - http://www.scopus.com/inward/record.url?scp=18444380876&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2265.2005.02255.x
DO - 10.1111/j.1365-2265.2005.02255.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 15853823
AN - SCOPUS:18444380876
SN - 0300-0664
VL - 62
SP - 547
EP - 553
JO - Clinical Endocrinology
JF - Clinical Endocrinology
IS - 5
ER -